AU4732499A - Compositions and methods for treating and preventing bone diseases using tocotrienols - Google Patents

Compositions and methods for treating and preventing bone diseases using tocotrienols Download PDF

Info

Publication number
AU4732499A
AU4732499A AU47324/99A AU4732499A AU4732499A AU 4732499 A AU4732499 A AU 4732499A AU 47324/99 A AU47324/99 A AU 47324/99A AU 4732499 A AU4732499 A AU 4732499A AU 4732499 A AU4732499 A AU 4732499A
Authority
AU
Australia
Prior art keywords
bone
tocotrienol
tocotrienols
vitamin
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47324/99A
Other languages
English (en)
Inventor
Ronald H Lane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipogenics Inc
Original Assignee
Lipogenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipogenics Inc filed Critical Lipogenics Inc
Publication of AU4732499A publication Critical patent/AU4732499A/en
Priority to AU2004200594A priority Critical patent/AU2004200594A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU47324/99A 1998-07-08 1999-07-08 Compositions and methods for treating and preventing bone diseases using tocotrienols Abandoned AU4732499A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2004200594A AU2004200594A1 (en) 1998-07-08 2004-02-16 Compositions and Methods for Treating and Preventing Bone Diseases Using Tocotrienols

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9210198P 1998-07-08 1998-07-08
US60092101 1998-07-08
PCT/US1999/015452 WO2000002553A1 (en) 1998-07-08 1999-07-08 Compositions and methods for treating and preventing bone diseases using tocotrienols

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2004200594A Division AU2004200594A1 (en) 1998-07-08 2004-02-16 Compositions and Methods for Treating and Preventing Bone Diseases Using Tocotrienols

Publications (1)

Publication Number Publication Date
AU4732499A true AU4732499A (en) 2000-02-01

Family

ID=22231570

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47324/99A Abandoned AU4732499A (en) 1998-07-08 1999-07-08 Compositions and methods for treating and preventing bone diseases using tocotrienols

Country Status (6)

Country Link
EP (1) EP1109548A4 (zh)
JP (1) JP2002520280A (zh)
CN (1) CN1316903A (zh)
AU (1) AU4732499A (zh)
ID (1) ID28460A (zh)
WO (1) WO2000002553A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
WO2002055071A1 (en) * 2001-01-15 2002-07-18 Kgk Synergize Compositions and methods for regulating lipoproteins and hypercholesterolmia with limonoids flavonoids and tocotrienols
CA2463142A1 (en) * 2001-10-10 2003-04-24 Pharmacia Italia Spa Methods for preventing and treating bone loss with steroid compounds
TWI331032B (zh) * 2002-05-01 2010-10-01 Hayashibara Biochem Lab
FR2841472B1 (fr) * 2002-06-28 2006-02-24 Agronomique Inst Nat Rech Composition nutritionnelle ou therapeutique contenant le compose hesperidine ou l'un de ses derives
FR2899106B1 (fr) * 2002-11-19 2015-04-24 Engelhard Lyon Utilisation d'une substance pour limiter et/ou prevenir la modification d'au moins un parametre biologique modifie au cours d'une irradiation
TW200524892A (en) * 2003-09-24 2005-08-01 Glaxo Group Ltd Calcilytic compounds
WO2006024096A1 (en) * 2004-08-31 2006-03-09 Chemgenex Pharmaceuticals Limited Method for modulating osteoclastogenesis
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
CA2582096C (en) * 2004-10-01 2014-01-07 Ramscor, Inc. Conveniently implantable sustained release drug compositions
ES2436181T3 (es) 2004-12-29 2013-12-27 Hill's Pet Nutrition Inc. Métodos para inhibir un declive en el aprendizaje y/o la memoria en animales
WO2007009111A1 (en) 2005-07-14 2007-01-18 Hill's Pet Nutrition, Inc. Method for prolonging the life of animals
US8288369B2 (en) * 2006-06-27 2012-10-16 University Of South Florida Delta-tocotrienol treatment and prevention of pancreatic cancer
JP5337405B2 (ja) 2007-09-17 2013-11-06 ザ・ホスピタル・フォー・シック・チルドレン ゴーシェ病の治療方法
AU2016200420B2 (en) * 2008-12-30 2017-03-02 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
JP5967936B2 (ja) * 2009-03-13 2016-08-10 株式会社明治 骨折リスクの低減及び／又は骨折の予防のための組成物
NL2008294C2 (en) * 2011-05-20 2013-08-19 Friesland Brands Bv Food composition comprising vitamin k and saturated fat.
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose
RU2016105843A (ru) 2013-07-22 2017-08-29 Огайо Стейт Инновейшн Фаундейшн Способы снижения частоты приливов

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0645533B2 (ja) * 1985-02-09 1994-06-15 ライオン株式会社 化粧料
US5574063A (en) * 1989-10-12 1996-11-12 Perricone; Nicholas V. Method and compositions for topical application of ascorbic acid fatty acid esters for treatment and/or prevention of skin damage

Also Published As

Publication number Publication date
EP1109548A4 (en) 2001-12-12
WO2000002553A1 (en) 2000-01-20
ID28460A (id) 2001-05-24
JP2002520280A (ja) 2002-07-09
EP1109548A1 (en) 2001-06-27
CN1316903A (zh) 2001-10-10

Similar Documents

Publication Publication Date Title
AU4732499A (en) Compositions and methods for treating and preventing bone diseases using tocotrienols
US5464862A (en) Method for inhibiting bone loss using centchroman derivatives
US5424331A (en) Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis
HU224957B1 (en) Composition for the treatment of osteoporosis and alterations due to menopause syndrome
US20040162247A1 (en) Therapeutic agent or osteoporosis comprising an active ingredient of quercetin derivatives
US6187811B1 (en) Methods for treating benign prostatic hyperplasia using tocotrienols
JP2008531602A (ja) 抗癌特性を有する化合物
MXPA04012740A (es) Composiciones y metodos para reduccion de sintomas inflamatorios y/o biomarcadores en pacientes femeninos.
JP2012511547A (ja) イソフラボン組成物
EP1589964B1 (en) Compounds having anti-proliferative properties
JP2001507363A (ja) イソプレノイド類とスタチン類との組合せによる腫瘍成長抑制方法
CN114225037B (zh) 一种预防或治疗骨质疏松症的组合物及其制剂和用途
WO2000064438A1 (en) Cardiovascular and bone treatment using isoflavones
US20040072765A1 (en) Cardiovascular and bone treatment using isoflavones
WO2005046702A1 (ja) 歯槽骨の吸収及び歯根膜喪失を抑制する方法及びそれに用いる内服組成物
US20240009177A1 (en) Combination compositions having anti-viral activities and uses thereof
AU2004200594A1 (en) Compositions and Methods for Treating and Preventing Bone Diseases Using Tocotrienols
EP0569415A1 (en) Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis
Halawa Effect of ciprofloxacin on the articular cartilage and epiphyseal growth plate cartilage in the growing albino rats and the possible protective role of vitamin E (α–Tocopherol): a histological and morphometric study
KR20150108371A (ko) 폐경기와 관련된 안면홍조의 발생을 치료/경감시키는데 사용하기 위한 n-메틸세로토닌 및 관련된 물질
EP3159003A2 (en) Composition for enhancing bone growth, preventing bone resorption disorders and for joint health
EP3494973B1 (en) Compositions comprising 7-o-genistein phosphate for use in the treatment of primary osteoporosis
KR20220032874A (ko) 2,4,6-트리페닐-1-헥센을 유효성분으로 포함하는 골질환 예방 또는 치료용 조성물
MXPA00012944A (en) Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome
CZ20004622A3 (cs) Přípravek k prevenci a/nebo léčbě osteoporozy a změn způsobených syndromem menopauzy

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted